From prevention to cure, Singapore builds upon a strong biomedical foundation and a diverse innovation ecosystem to take on COVID-19. Public and private players have been rapidly innovating solutions from the start.

Singapore’s innovators rallied quickly in the face of the COVID-19 pandemic, from delivering detection methods powered by artificial intelligence (AI) in weeks, to launching human vaccine trials in a matter of months. Such speed is possible because of Singapore’s strong foundation in health and biomedical sciences, and its persistent focus on innovation.

From preventing the spread of the disease, to testing and potential life-saving treatments, companies, both big and small, are partnering with public institutions, tapping on deep local expertise to ensure there’s an innovation to take on the virus every step of the way.

Diagnosing from a distance
While a cure is in the making, smarter telehealth solutions are helping us diagnose and detect remotely, offering consultations and tracking wherever people are.

We are bringing medical consultations online across APAC. COVID-19 Medical Advisory Clinic onboard offers consultations through a full-suite app. Within five minutes, users can consult a doctor and get checked. And if a COVID-19 infection is suspected, the medical team is on hand to provide online and in-person assistance.